Bath-PUVA therapy decreases infiltrating CCR4-expressing tumor cells and regulatory T cells in patients with mycosis fungoides

Clinical Lymphoma, Myeloma and Leukemia

Volumn 13, Issue 3, 2013, Pages 273-280

  Kato, Hiroshi ^a   Saito, Chiyo ^a   Ito, Erika ^a   Furuhashi, Takuya ^a   Nishida, Emi ^a   Ishida, Takashi ^a   Ueda, Ryuzo ^a   Inagaki, Hiroshi ^a   Morita, Akimichi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Bath PUVA therapy; CCR4; Mycosis fungoides; Regulatory T cell; Thymus and activation regulated chemokine (TARC)

Indexed keywords

CD3 ANTIGEN; CHEMOKINE RECEPTOR CCR4; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYCOSIS FUNGOIDES; PSORIASIS; PUVA; REGULATORY T LYMPHOCYTE; SKIN DEFECT;

ADULT; AGED; AGED, 80 AND OVER; BATHS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METHOXSALEN; MIDDLE AGED; MYCOSIS FUNGOIDES; PHOTOSENSITIZING AGENTS; PUVA THERAPY; RECEPTORS, CCR4; T-LYMPHOCYTES, REGULATORY;

EID: 84877781015     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2012.12.002     Document Type: Article

References (31)

1. S.J. Whittaker Cutaneous lymphomas and lymphocytic infiltrates T. Burns, S.M. Breathnach, N.H. Cox, Rook's Textbook of Dermatology 8th ed. 2010 Blackwell Publishing Oxford 10 13
2. R. Willemze Cutaneous T-cell lymphoma J.L. Bolognia, J.L. Jorizzo, R.P. Rapini, Dermatology 2nd ed. 2007 1925 1929 Philadelphia
3. R. Van Doorn, C.W. Van Haselen, P.C. van Voorst Vader Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients Arch Dermatol 136 2000 504 510 (Pubitemid 30212962)
4. H.S. Zackheim, M. Kashani-Sabet, S. Amin Topical corticosteroids for mycosis fungoides Experience in 79 patients Arch Dermatol 134 1998 949 954 (Pubitemid 28385316)
5. A. Morita, A. Takashima, M. Nagai Treatment of a case of mycosis fungoides and one of parapsoriasis en plaque with topical PUVA using a monofunctional furocoumarin derivative, 4,6,4′-trimethylangelicin J Dermatol 17 1990 545 549 (Pubitemid 20382370)
6. V. Brazzelli, M. Antoninetti, S. Palazzini Narrow-band ultraviolet therapy in early-stage mycosis fungoides: study on 20 patients Photodermatol Photoimmunol Photomed 23 2007 229 233 (Pubitemid 350055610)
7. C. Saito, A. Maeda, A. Morita Bath-PUVA therapy induces circulating regulatory T cells in patients with psoriasis J Dermatol Sci 53 2009 231 233
8. T. Ishida, R. Ueda CCR4 as a novel molecular target for immunotherapy of cancer Cancer Sci 97 2006 1139 1146 (Pubitemid 44430638)
9. T. Ishida, A. Utsunomiya, S. Iida Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome Clin Cancer Res 9 2003 3625 3634 (Pubitemid 37169227)
10. T. Ishida, H. Inagaki, A. Utsunomiya CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified Clin Cancer Res 10 2004 5494 5500 (Pubitemid 39100487)
11. T. Ishii, T. Ishida, A. Utsunomiya Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphoma Clin Cancer Res 16 2010 1520 1531
12. K. Yamamoto, A. Utsunomiya, K. Tobinai Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma J Clin Oncol 28 2010 1591 1598
13. T. Imai, M. Nagira, S. Takagi Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine Int Immunol 11 1999 81 88 (Pubitemid 29037591)
14. T. Kakinuma, K. Nakamura, M. Wakugawa Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity J Allergy Clin Immunol 107 2001 535 541 (Pubitemid 32210037)
15. T. Kakinuma, M. Sugaya, K. Nakamura Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides J Am Acad Dermatol 48 2003 23 30 (Pubitemid 36091529)
16. M. Ozawa, K. Ferenczi, T. Kikuchi 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions J Exp Med 189 1999 711 718 (Pubitemid 29193372)
17. R.L. Edelson Dohi memorial lecture Cutaneous T cell lymphoma J Dermatol 14 1987 397 410 (Pubitemid 18003976)
18. A. Maeda Extracorporeal photochemotherapy J Dermatol Sci 54 2009 150 156
19. C.L. Berger, A.L. Xu, D. Hanlon Induction of human tumor-loaded dendritic cells Int J Cancer 91 2001 438 447 (Pubitemid 32115096)
20. T. Imai, M. Baba, M. Nishimura The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4 J Biol Chem 272 1997 15036 15042 (Pubitemid 27251781)
21. A. Iellem, M. Mariani, R. Lang Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells J Exp Med 194 2001 847 853 (Pubitemid 32983019)
22. H. Yagi, T. Nomura, K. Nakamura Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells Int Immunol 16 2004 1643 1656
23. M. Girardi, P.W. Heald, L.D. Wilson The pathogenesis of mycosis fungoides N Engl J Med 350 2004 1978 1988 (Pubitemid 38580201)
24. M.A. Wasik, E.C. Vonderheid, R.D. Bigler Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma Clinical and prognostic implications Arch Dermatol 132 1996 42 47 (Pubitemid 26024809)
25. F. Weber, M. Schmuth, N. Sepp Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides Acta Derm Venereol 85 2005 329 332 (Pubitemid 41113515)
26. T. Nishioka, E. Nishida, R. Iida In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules Immunol Lett 121 2008 97 104
27. M. Bonelli, A. Savitskaya, C.W. Steiner Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus J Immunol 182 2009 1689 1695
28. J.D. Fontenot, M.A. Gavin, A.Y. Rudensky Foxp3 programs the development and function of CD4+CD25+ regulatory T cells Nat Immunol 4 2003 330 336 (Pubitemid 36432314)
29. + regulatory T cells Int Immunol 4 2004 889 899
30. S. Beissert, A. Schwarz, T. Schwarz Regulatory T cells J Invest Dermatol 126 2006 15 24 (Pubitemid 43336089)
31. L.M. Gjerdrum, A. Woetmann, N. Odum FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival Leukemia 21 2007 2512 2518 (Pubitemid 350148895)